Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer
Wydra, D.; Emerich, J.
Ginekologia Polska 73(11): 1044-1047
2002
ISSN/ISBN: 0017-0011 PMID: 12722397 Document Number: 547974
The paper presents a treatment of peritoneal spread of ovarian cancer with intraperitoneal hyperthermic perfusion chemotherapy. Hyperthermic antiblastic perfusion was carried out throughout the abdomino-pelvic cavity for 90 min, at the temperature of 41-42 degrees C, with cisplatin (50 mg/l). Perfusion was performed with 4 liters of Maxwell liquid. The perfusion rate was 1200-2000 ml/min. There was no complication during and after procedure.
Document emailed within 1 workday
Related Documents
Giseĭnov, K.D.; Beliaev, A.M.; Senchik, K.I.; Maksimov, S.I.; Urmancheeva, A.F.; Gafton, G.I.; Mikaia, N.A.; Beliaeva, O.A.; Kireeva, G.S.; Gorodnova, T.V.; Matveeva, N.S. 2014: Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer Voprosy Onkologii 60(3): 343-347Samartzis, K.; Thomakos, N.; Liontos, M.; Kollia, D.; Malakasis, A.; Haidopoulos, D.; Bamias, A.; Rodolakis, A.; Loutradis, D. 2018: Is it the right moment to include hyperthermic intraperitoneal chemotherapy as standard in ovarian cancer management? a reappraisal Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 19-23
Robella, M.; Vaira, M.; Marsanic, P.; Mellano, A.; Borsano, A.; Cinquegrana, A.; Sottile, A.; De Simone, M. 2014: Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) Minerva Chirurgica 69(1): 27-35
Xia, W.; Hu, Y.; Mou, T.; Chen, T.; Yu, J.; Li, G. 2014: Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis Zhonghua Wei Chang Wai Ke Za Zhi 17(11): 1087-1091
Wydra, D.; Sawicki, J.; Sawicki, S.; Ciach, K.; Emerich, J. 2003: Laboratory investigation of flow characteristics during intraperitoneal hyperthermic perfusion chemotherapy Ginekologia Polska 74(9): 918-924
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Kokubun, M.; Fujimoto, S.; Shrestha, R.D.; Kobayashi, K.; Kiuchi, S.; Konno, C.; Ohta, M.; Takahashi, M. 1991: Prevention of scald injury due to intraperitoneal hyperthermic perfusion for far-advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 2058-2062
Fujimoto, S.; Shrestha, R.D.; Kokubun, M.; Kobayashi, K.; Kiuchi, S.; Konno, C.; Okui, K. 1990: Clinical results of intraperitoneal hyperthermic perfusion combined with surgery in patients with peritoneal recurrence from gastric cancer Nihon Geka Gakkai Zasshi 91(2): 201-205
Lygidakis, N.J.; Patil, A.; Giannoulis, K.; Fukuda, T.; Kumar, R. 2010: Laparoscopic hyperthermic intraperitoneal chemotherapy as adjuvant modality following radical surgery for advanced rectal cancer a new look to an old problem Hepato-Gastroenterology 57(97): 73-75
Lepistö, A. 2016: Novel approved form of treatment for colonic cancer with peritoneal metastases - radicality-aimed surgery combined with hyperthermic intraperitoneal chemotherapy Duodecim; Laaketieteellinen Aikakauskirja 132(10): 912-916
Bozer, M.; Türkçapar, N.; Bayar, S.; Kocaoglu, H. 2005: Intraperitoneal hyperthermic perfusion may induce bacterial translocation Hepato-Gastroenterology 52(61): 111-114
Lei, Z.Y.; Guan, T.P.; Luo, J.L.; Tang, H.S.; Cui, S.Z. 2019: Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC Zhonghua Wei Chang Wai Ke Za Zhi 22(12): 1115-1117
Isawa, E.; Sumida, M. 1995: Comparison of temperatures from 7 points in the patients under intraperitoneal hyperthermic perfusion Masui. Japanese Journal of Anesthesiology 44(11): 1472-1476
Di Miceli, D.; Cina, C.; Fiorillo, C.; Doglietto, G.B.; Alfieri, S. 2018: The hyperthermic intraoperative intraperitoneal chemotherapy in the treatment of advanced abdominopelvic cancer. Personal experience on 103 procedures during a seventeen year period in a single Italian center European Review for Medical and Pharmacological Sciences 22(3): 796-801
Graziosi, L.; Bugiantella, W.; Cavazzoni, E.; Donini, A. 2009: Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report Il Giornale di Chirurgia 30(5): 237-239
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
De Gramont, A.; Marpeau, L.; Demuynck, B.; Louvet, C.; Varette, C.; Gonzalez-Canali, G.; Pigné, A.; Herbulot, P.; Lagadec, B.; Cady, J. 1991: Results of intraperitoneal chemotherapy of ovarian cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(3): 387-392
Miron, L.; Onofriescu, M.; Marinca, M. 2008: Controversies regarding intraperitoneal chemotherapy for advanced ovarian cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 583-589
Meng, F.H. 1994: Care of ovarian cancer treated with intraperitoneal chemotherapy Zhonghua Hu Li Za Zhi 29(1): 24-26
Mura, G.; Framarini, M.; Vagliasindi, A.; Cavaliere, D.; Tauceri, F.; Solfrini, G.; Milandria, C.; Verdecchia, G.M. 2007: Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma Chirurgia Italiana 59(2): 217-223